AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Federal National Mortgage Association
Video analysis: FNMA
All videosNo video analysis for this stock yet. Request one from our team.
News: FNMA
VantageScore 4.0, the Mortgage Credit Score, Now FHFA Approved for All Lenders Originating Fannie Mae and Freddie Mac Mortgage Loans
SAN FRANCISCO--(BUSINESS WIRE)--Federal Housing Finance Agency (FHFA) Director Bill Pulte has directed Government Sponsored Enterprises (GSEs), Fannie Mae and Freddie Mac, to accept VantageScore 4.0 credit scores from all mortgage origination lenders, effective immediately. The most advanced credit score available for mortgage origination today, VantageScore 4.0, uses 400% more data to generate a credit score than legacy credit scores, providing a more predictive view of borrower creditworthine.
Oksenholt Capital Publishes USFTMC Transaction Blueprint for Fannie Mae, Freddie Mac & U.S. Financial Technology
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oksenholt Capital Management LLC today published USFTMC: One Parent, Two Charters - A Transaction Blueprint & Call to Action for Fannie Mae, Freddie Mac & U.S. Financial Technology, a follow-up to its August 25 white paper proposing a publicly traded parent over Fannie Mae and Freddie Mac. The follow-up gets into the legal & transaction mechanics, mortgage rates, UMBS liquidity, Treasury's capital structure and the biggest question raised by a com.
Fannie Mae Releases July 2026 Monthly Summary
WASHINGTON, Aug. 26, 2026 /PRNewswire/ -- Fannie Mae's (OTCQB: FNMA) July 2026 Monthly Summary is now available. The monthly summary report contains information about Fannie Mae's monthly and year-to-date activities for our gross mortgage portfolio, mortgage-backed securities and other guarantees, interest rate risk measures, and serious delinquency rates.
Oksenholt Capital Management LLC Releases White Paper; One Company, Two Charters: A Path to a $1 Trillion Fannie-Freddie Platform
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oksenholt Capital Management LLC today released a white paper outlining a proposed structure for U.S. Financial Technology and Mortgage Corporation, a Texas-based public holding company that would sit above Fannie Mae and Freddie Mac. Their jointly owned U.S. Financial Technology platform would remain inside the consolidated group. The proposal is designed to capture value that is difficult to surface under the current structure: operating and technology syne.
Following Up On Fannie Mae IPO Roadmap
Fannie Mae and Freddie Mac face renewed investor interest following recent legal and policy developments. Three key events - management exodus, stress test results, and a court ruling against the Net Worth Sweep - have stabilized FNMAs shares near $10. The DC District Court affirmed that the government violated shareholder rights in the 2012 Net Worth Sweep, potentially shaping future restructuring.
Fannie Mae Stock Dips on Report of High-Ranking Departures at Mortgage Giant
At least 10 senior Fannie Mae employees are leaving the secondary mortgage giant, with a senior administration official saying they were terminated.
Fannie Mae Hit by Turmoil in Senior Ranks as at Least 10 Executives Depart
The departures are raising concern in the industry about stability inside the government mortgage giant.
Fannie Mae Announces Sale of Non-Performing Loans
Fannie Mae Announces Sale of Non-Performing Loans PR Newswire WASHINGTON, Aug. 19, 2026
Similar companies
-
Federal Home Loan Mortgage Corporation
FMCC
·
Other OTC
Compare
-
Computershare Limited
CMSQF
·
Other OTC
Compare
-
Singapore Exchange Limited
SPXCF
·
Other OTC
Compare
-
PT Bank Negara Indonesia (Persero) Tbk
PBNNF
·
Other OTC
Compare
-
FinecoBank Banca Fineco S.p.A.
FCBBF
·
Other OTC
Compare
-
China Galaxy Securities Co., Ltd.
CGXYY
·
Other OTC
Compare